Navigation Links
New Device May Reduce Repeat Breast Cancer Surgeries
Date:9/12/2012

By Kathleen Doheny
HealthDay Reporter

TUESDAY, Sept. 11 (HealthDay News) -- A new device meant to help surgeons determine in the operating room if they have removed all cancerous breast cancer tissue may help reduce repeat surgeries after lumpectomy without compromising cosmetic effects, according to a new study.

The device, called MarginProbe, emits an electric field and senses a return signal from the tissue examined. Cancerous tissue provides a different electromagnetic signature than normal tissue, the researchers explained.

"This can potentially decrease having to go back to the operating room and with no real effect on your [cosmetic] outcome," said study leader Dr. Susan Boolbol, chief of breast surgery at Beth Israel Medical Center, in New York City.

The study of nearly 500 patients undergoing breast-conserving surgery found little difference in the volume of tissue removed when the device was used compared to traditional detection methods.

"The reality is, most of the time we leave the operating room and we don't know if we have a clear margin [with all cancer removed] or not," Boolbol said. Doctors wait for the pathology report to find that out, which can take a week or two. With the new device, the wait time is about five minutes.

"Everything still goes through pathology," Boolbol said. But the MarginProbe is another tool that might help reduce the odds of needing a subsequent surgery, she said.

Boolbol is scheduled to present the findings Thursday at the American Society of Clinical Oncology's breast cancer symposium in San Francisco.

In June, the radiation-free device won the blessing of a U.S. Food and Drug Administration advisory panel. The FDA usually follows the advisory panel's recommendations, so device approval is anticipated.

For the study, Boolbol and her colleagues randomly assigned 495 breast cancer patients to receive the MarginProbe after lumpectomy or not receive it. Of those, 161 had early cancer known as ductal carcinoma in situ. The others had invasive cancers.

Where the device detected cancer cells near the edge or surface of the sample examined, surgeons removed additional tissue in the same procedure.

Typically, about 40 percent of lumpectomy patients need another surgery because of the difficulty distinguishing between healthy and cancerous cells in tissue around the tumor.

"We looked at whether we could lower the [repeat surgery] rate by using this device," Boolbol said. The patients were followed for two months to see if they needed a repeat surgery. For those with ductal carcinoma in situ, 13 percent of the probe group needed a repeat surgery, compared to 37 percent of the control group.

Among women with invasive breast cancer, 17 percent in the device group and 33 percent in the comparison group required more surgery.

Looking at the volume of tissue excised, the researchers said not much more tissue was removed when the device was used compared to tissue removed in the initial and subsequent surgeries among the control-group patients, Boolbol said.

Dr. Laura Kruper, director of the Cooper Finkel Women's Health Center and co-director of the breast cancer program at City of Hope Comprehensive Cancer Center in Duarte, Calif., said the device looks promising. However, she thinks more research is needed.

"I would like to see it [used] in a larger population," she said. If the results are repeated in larger studies, it could be a welcome addition to doctors' techniques, she said.

The expected cost of the MarginProbe in the United States, if approved, is not yet known, said Michael Graffeo, a spokesman for its maker, Dune Medical Devices. In Europe, where the device is available, each probe (one per patient) sells for about 600 euros or $760, he said. This is much less than the cost of re-operation, he noted.

The device is also being studied for use with prostate cancer, the company said.

Data and conclusions presented at meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information

To learn more about breast cancer surgery, visit the American Cancer Society.

SOURCES: Laura Kruper, M.D, director, Cooper Finkel Women's Health Center and co-director, breast cancer program, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Susan Boolbol, M.D., chief, breast surgery, Beth Israel Medical Center, New York City; Michael Graffeo, spokesman, Dune Medical Devices; Sept. 13, 2012, presentation, American Society of Clinical Oncology Breast Cancer Symposium, New York City


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy
2. In Rat Study, Eye Device Shows Promise for Restoring Sight
3. Biochip-based device for cell analysis
4. New device warns workers of high levels of airborne metals in minutes rather than weeks
5. Device implanted in brain has therapeutic potential for Huntingtons disease
6. US Drug Watchdog Now Offers To Help All Recipients Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Get To The Best Attorneys Regardless If Their Device Has Failed
7. Oakworks Medical, a Division of Oakworks Inc., Oakworks.com, Manufacturer of Medical Tables and Positioning Devices Announces ISO 13485 Certification
8. Device is effective in managing incontinence after surgery
9. Adena Delivers Instant Health Information to Mobile Devices
10. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
11. Popularity Causing Several Week Lag In Delivery Of 'Plug In' Device To Start Saving On Electricity Between 8% and 20%
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Device May Reduce Repeat  Breast Cancer Surgeries
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
Breaking Medicine Technology: